Medicus Pharma (MDCX) Competitors $4.00 -0.05 (-1.23%) As of 02/21/2025 03:57 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsTrends MDCX vs. NBTX, TIL, CDTX, IVVD, OGI, GLSI, ACRV, ACRS, VXRT, and NLTXShould you be buying Medicus Pharma stock or one of its competitors? The main competitors of Medicus Pharma include Nanobiotix (NBTX), Instil Bio (TIL), Cidara Therapeutics (CDTX), Invivyd (IVVD), Organigram (OGI), Greenwich LifeSciences (GLSI), Acrivon Therapeutics (ACRV), Aclaris Therapeutics (ACRS), Vaxart (VXRT), and Neoleukin Therapeutics (NLTX). These companies are all part of the "pharmaceutical products" industry. Medicus Pharma vs. Nanobiotix Instil Bio Cidara Therapeutics Invivyd Organigram Greenwich LifeSciences Acrivon Therapeutics Aclaris Therapeutics Vaxart Neoleukin Therapeutics Medicus Pharma (NASDAQ:MDCX) and Nanobiotix (NASDAQ:NBTX) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their community ranking, valuation, dividends, media sentiment, analyst recommendations, institutional ownership, earnings, risk and profitability. Does the media favor MDCX or NBTX? In the previous week, Nanobiotix had 3 more articles in the media than Medicus Pharma. MarketBeat recorded 5 mentions for Nanobiotix and 2 mentions for Medicus Pharma. Nanobiotix's average media sentiment score of 0.74 beat Medicus Pharma's score of 0.67 indicating that Nanobiotix is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Medicus Pharma 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Nanobiotix 0 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals and insiders believe in MDCX or NBTX? 38.8% of Nanobiotix shares are held by institutional investors. 3.5% of Nanobiotix shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Do analysts rate MDCX or NBTX? Medicus Pharma currently has a consensus target price of $10.00, indicating a potential upside of 150.00%. Nanobiotix has a consensus target price of $12.00, indicating a potential upside of 220.00%. Given Nanobiotix's higher possible upside, analysts plainly believe Nanobiotix is more favorable than Medicus Pharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Medicus Pharma 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50Nanobiotix 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67 Is MDCX or NBTX more profitable? Company Net Margins Return on Equity Return on Assets Medicus PharmaN/A N/A N/A Nanobiotix N/A N/A N/A Does the MarketBeat Community favor MDCX or NBTX? Nanobiotix received 9 more outperform votes than Medicus Pharma when rated by MarketBeat users. However, 100.00% of users gave Medicus Pharma an outperform vote while only 61.11% of users gave Nanobiotix an outperform vote. CompanyUnderperformOutperformMedicus PharmaOutperform Votes2100.00% Underperform VotesNo VotesNanobiotixOutperform Votes1161.11% Underperform Votes738.89% Which has preferable earnings & valuation, MDCX or NBTX? Medicus Pharma has higher earnings, but lower revenue than Nanobiotix. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMedicus PharmaN/AN/AN/AN/AN/ANanobiotix$39.18M4.51-$42.97MN/AN/A SummaryNanobiotix beats Medicus Pharma on 8 of the 11 factors compared between the two stocks. Get Medicus Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for MDCX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MDCX vs. The Competition Export to ExcelMetricMedicus PharmaPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$43.93M$7.07B$5.85B$9.15BDividend YieldN/A2.76%4.76%3.85%P/E RatioN/A2.5616.5114.19Price / SalesN/A304.55450.0276.60Price / CashN/A65.6738.0134.95Price / BookN/A6.717.644.63Net IncomeN/A$138.11M$3.18B$245.69M7 Day Performance8.70%-2.54%-1.95%-2.68%1 Month Performance42.35%-2.00%-0.23%-2.16%1 Year PerformanceN/A-5.04%16.69%12.90% Medicus Pharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MDCXMedicus PharmaN/A$4.00-1.2%$10.00+150.0%N/A$43.93MN/A0.00N/AUpcoming EarningsGap UpHigh Trading VolumeNBTXNanobiotix2.1369 of 5 stars$3.60-8.9%$12.00+233.3%-40.5%$169.67M$39.18M0.00100Gap DownTILInstil Bio2.9407 of 5 stars$25.72+2.9%$114.00+343.2%+88.3%$167.95MN/A-2.22410News CoverageCDTXCidara Therapeutics3.9216 of 5 stars$23.81-0.8%$32.20+35.2%+55.6%$167.86M$63.90M-0.9390IVVDInvivyd3.3805 of 5 stars$1.40-4.1%$7.89+463.4%-55.6%$167.47MN/A-0.71100Gap UpOGIOrganigram0.7394 of 5 stars$1.32-2.9%N/A-34.8%$166.53M$117.47M-3.47860GLSIGreenwich LifeSciences2.0796 of 5 stars$12.59+0.5%$38.00+201.8%-9.2%$165.56MN/A-15.743ACRVAcrivon Therapeutics2.3269 of 5 stars$5.31+1.0%$23.67+345.7%+45.8%$165.35MN/A-1.9758Short Interest ↓ACRSAclaris Therapeutics2.2437 of 5 stars$2.31+0.4%$11.00+376.2%+87.1%$165.00M$31.25M-4.44100VXRTVaxart1.5405 of 5 stars$0.73-0.7%$4.00+451.6%-49.4%$164.95M$7.38M-1.77120NLTXNeoleukin TherapeuticsN/A$17.35-5.8%N/A-41.9%$163.06MN/A-5.5890News CoverageHigh Trading Volume Related Companies and Tools Related Companies Nanobiotix Alternatives Instil Bio Alternatives Cidara Therapeutics Alternatives Invivyd Alternatives Organigram Alternatives Greenwich LifeSciences Alternatives Acrivon Therapeutics Alternatives Aclaris Therapeutics Alternatives Vaxart Alternatives Neoleukin Therapeutics Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:MDCX) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredWe recommended Palantir in 2021, now we’re recommending this...I believe it could offer you a MAJOR boost to your retirement. And it pays huge dividends to give you a nic...Behind the Markets | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medicus Pharma Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Medicus Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
